EMPLOYMENT AGREEMENTEmployment Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • North Carolina
This EMPLOYMENT AGREEMENT (the “Agreement”) is entered into effective March 23, 2017 (the “Effective Date”), by and between Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and Kevin Laliberte (the “Employee”).
SERVICES AGREEMENTServices Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS SERVICES AGREEMENT (this “Agreement”) is entered into as of the 1st day of April, 2016, by and between PBM Capital Group, LLC, a Delaware limited liability company (“PBM”), and Dova Pharmaceuticals, LLC (the “Company”).
YM477 LICENSE AGREEMENTYm477 License Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Agreement is made as of August 15, 2005, by and between Astellas Pharma Inc., a company organized and existing under the laws of Japan and having its principal office at 3·11, Nihonbasbi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (“Licensor”) and AkaRx Corp., a company organized and existing under the laws of Delaware and having its principal office at Mack Centre IV, 4th Floor, 61 S. Paramus Road, Paramus, NJ 07652 (“Licensee”).
STOCK PURCHASE AGREEMENT BETWEEN EISAI INC. and PBM AKX HOLDINGS, LLC Dated as of March 29, 2016Stock Purchase Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
STOCK PURCHASE AGREEMENT, dated as of March 29, 2016 (this “Agreement”), between Eisai Inc., a Delaware corporation (“Seller”), and PBM AKX Holdings, LLC, a Delaware limited liability company (“Purchaser”). Seller and Purchaser are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
GUARANTEEGuarantee • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Guarantee is made by PBM Capital Investments, LLC, a Delaware limited liability company (“Guarantor”), in favor of Eisai Inc., a Delaware corporation (“Seller”), as of March 30, 2016 (this “Guarantee”). Guarantor and Seller are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
SECURITY AGREEMENTSecurity Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Security Agreement (“Security Agreement”) is made as of March 30, 2016, by and between AkaRx, Inc., a Delaware corporation (“Debtor”), and Eisai Inc., a Delaware corporation (“Secured Party”). Debtor and Secured Party are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
TRANSITION SERVICES AGREEMENT by and between Eisai Inc. and AkaRx, Inc. Dated as of March 30, 2016Transition Services Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Transition Services Agreement (this “Agreement”) dated as of March 30, 2016 (the “Effective Date”), by and between Eisai Inc. a Delaware corporation (“Seller”), and AkaRx, Inc., a Delaware corporation (the “Company”). Seller and the Company are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • June 2nd, 2017 • Dova Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 19th day of September, 2016, by and among Dova Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, each of the stockholders listed on Schedule B hereto, each of whom is referred to herein as a “Key Holder” and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 5.9 hereof.
